PROFESSIONAL EXPERIENCE
As a Deloitte Consultant, I was introduced to private capital through a side initiative that I co-led which required me to conduct market analysis on exciting and innovative startups within Financial Services and Healthcare. This experience was truly fulfilling and inspired me to apply to Yale’s School of Management with the goal of pursuing my passion for Venture Capital and Impact Investing.
Since enrolling at Yale's School of Management MBA Program, I have developed hands-on experience from both the investor and entrepreneurial side of Impact Investing and Private Capital.
Monitor Deloitte
Manager - Strategy​
​
BOSTON | 2023 - PRESENT
Lead enterprise AI transformation and GenAI commercialization initiatives for Fortune 500 clients across consumer and financial services sectors
-
Directed multi-million-dollar GenAI transformation projects, managing cross-functional teams of PhDs and engineers
​​
-
Led design and value quantification of AI-enabled product search platform delivering 60% workflow efficiency gains and $2.7M cost impact
​​
-
Oversaw $81M cross-offering GenAI investment roadmap to scale AI capabilities across the firm
​
-
Defined functional requirements and commercialization strategy for Deloitte's autonomous agent offering (Zora AI)
​
-
Served as Change & Adoption Lead for 1,000-person Strategy practice, increasing AI adoption from 20% to 85%+
ASTIA FUND
MBA INVESTMENT INTERN
​
REMOTE | 2021 - 2023
The Astia Fund invests in Series-A - Series B, high-performing, women-led companies that solve global problems
-
Led due-diligence and performance evaluation of ventures sourced through Astia’s proven Expert Sift, a data-driven model that uses wisdom-of-the-crowd techniques to eliminate bias through the venture funding process
​
-
Pitched investment recommendations to Astia’s Managing Partners during weekly investment team meetings
​
-
Worked alongside Astia’s global network of Advisors to evaluate investments with the highest likelihood of success
Astia's Recent Exits
OVERDOSE GUARDIAN - YALE STARTUP
BUSINESS LEAD
​
NEW HAVEN, CT | 2021 - 2023
Overdose Guardian (recently rebranded from EnlighteN) is a health-tech startup committed to the design of a discreet wearable biosensor that can immediately detect opioid overdose-events and notify first-responders. Our mission is to prevent opioid-induced overdose deaths
-
Ran the venture’s business development including ongoing design of a detailed business plan
​
-
Invited to compete in and was a finalist for the 2022 American Academy of Pain Medicine Innovation Challenge
​
-
Hosted a session for Yale’s 2022 Innovation Summit – pitching our software and sharing insights with other teams
​
-
Awarded the 2023 VentureWell E-Team Grant and accepted to the Propel early-stage innovator training program
​
Pitching at the Yale Innovation Summit
PYRAMIDIA VENTURE BUILDER
MBA SUMMER INTERN
​
NAIROBI, KENYA | SUMMER 2022
Pyramidia is a purpose-led venture builder of climate-positive agri-food businesses serving the East-African consumer
-
Facilitated the ideation, development, and scale of sustainable agri-food businesses to create circular systems for an increasingly food deprived region of East Africa
​
-
Consulted Pyramidia’s portfolio company – Womega – by conducting trials to improve the current process for harvesting the high-nutrient protein ‘omena,’ reducing current product rejection rate from 70% to 25%
​
-
Drove the due-diligence and design of investor materials in preparation of Series A investment pitches
​
The Womega Team
DELOITTE CONSULTING (EARLY CAREER)
SENIOR CONSULTANT - STRATEGY & ANALYTICS
​
BOSTON, MA | 2017 - 2021
I focused on the design and implementation of large scale tech strategy transformations
Senior Consultant (2021)​
-
Co-led the design of a tech modernization schedule, outlining a 5-year, $200M+ investment plan
Consultant (2019 - 2021)
-
Managed a team of 5 developers to implement a best-in-class analytics application, decreasing operating costs and achieving $3M in savings
Business Technology Analyst (2017 - 2019)
-
Co-Led the mid-market research team to identify and publish emerging trends & disruptive activities in Healthcare
Call
Write
© 2026 by Liam Bartlett
+1-782-292-0922